BCBS – Somatic Biomarker Testing (Including Liquid Biopsy) for Targeted Treatment and Immunotherapy in Non-Small-Cell Lung Cancer (EGFR, ALK, BRAF, ROS1, RET, MET, KRAS, HER2, PD-L1, TMB)- update

Effective 2/9/2023

Update Coding Section

§ Added: 81445, 81455, 88341 and 0326U

§ Removed Coding bullet

o ICD-10-CM does not have specific coding for non-small-cell lung cancer. The malignant neoplasm of lung codes above would be used.

Source: https://www.bcbsks.com/medical-policies/somatic-biomarker-testing-including-liquid-biopsy-targeted-treatment-and